Sahni V Anik, Silverman Stuart G
Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Cancer Imaging. 2009 Jul 6;9(1):44-55. doi: 10.1102/1470-7330.2009.0005.
Percutaneous image-guided biopsy of renal masses is a safe and accurate procedure. Although once reserved for the diagnosis of unresectable renal cell carcinoma, metastases, lymphoma, and infection, today percutaneous image-guided biopsy has an expanded role. There is increasing awareness that a substantial proportion of small, solid renal masses are benign neoplasms. Although imaging can be used to diagnose most of them, some are incorrectly believed to represent renal cell carcinoma and unnecessary surgery may be performed. Based largely on advances in cytological techniques, percutaneous biopsy can be now be used to diagnose benign neoplasms and thus prevent them from being treated unnecessarily. Concurrent advances in percutaneous ablation have also promoted its use. As a result, there are 8 established indications for percutaneous biopsy, and reason to believe that the number of indications will expand further in the future.
经皮影像引导下肾肿块活检是一种安全且准确的操作。虽然该操作曾一度仅用于诊断无法切除的肾细胞癌、转移瘤、淋巴瘤及感染,但如今其作用已得到扩展。人们越来越意识到,相当一部分小的实性肾肿块是良性肿瘤。尽管影像学可用于诊断大多数此类肿块,但有些被错误地认为是肾细胞癌,从而可能进行不必要的手术。很大程度上基于细胞学技术的进步,现在经皮活检可用于诊断良性肿瘤,从而避免对其进行不必要的治疗。同时,经皮消融技术的进步也推动了其应用。因此,经皮活检有8个既定的适应证,而且有理由相信未来适应证的数量还会进一步增加。